CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities:
Net income (loss)	$ (3,106,984)	$ 926,150
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Depreciation and amortization	2,227,895	1,667,979
Amortization of deferred financing costs and debt discounts and premiums as interest	11,480	77,609
Amortization of key money loans	(40,125)	(40,125)
Loss on acquisition	133,521
Unrealized loss on interest rate swap	68,690	245,891
Changes in operating assets and liabilities:
Accounts receivable	(38,806)	(117,535)
Due from related parties	(261,459)	(184,707)
Prepaid expenses and other assets	(289,263)	(130,908)
Accounts payable, accrued expenses and other	527,846	643,478
Due to related parties	1,130,818	347,209
Net cash provided by operating activities	363,613	3,435,041
Cash Flows from Investing Activities:
Acquisition of hotel property, net	(12,240,256)
Capital improvements	(127,203)	(700,684)
Net cash used in investing activities	(12,367,459)	(700,684)
Cash Flows from Financing Activities:
Proceeds from issuance of common stock	8,651,703	14,556,393
Payment of commissions and dealer manager fees and stockholder servicing fees	(728,011)	(1,115,642)
Proceeds from mortgage note	2,000,000
Proceeds from other debt	1,018,917
Payments of mortgage notes principal	(108,132)	(1,744,000)
Payment of deferred financing costs	94,770
Payments of loans from affiliates		(6,600,000)
Distributions to stockholders	(938,267)	(695,683)
Distributions to noncontrolling interest	(98,000)	(698,250)
Contributions from noncontrolling interest	120,050
Repurchase of common stock	(305,959)	(23,125)
Net cash provided by financing activities	9,517,531	3,679,693
Increase (decrease) in cash and cash equivalents and restricted cash	(2,486,315)	6,414,050
Cash and cash equivalents and restricted cash, beginning of period	13,001,797	3,798,152
Cash and cash equivalents and restricted cash, end of period	$ 10,515,482	$ 10,212,202